Nawar Latif

Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer

Payal D. Shah, Stephanie L. Wethington, Cheyenne Pagan et al. · Gynecologic Oncology · 2021 · 111 citations · Full text

The First 5 Years of Uterus Transplant in the US

Liza Johannesson, Elliott G. Richards, Vikrant Reddy et al. · JAMA Surgery · 2022 · 86 citations · Full text

Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program

Ashley Graul, Nawar Latif, Xiaochen Zhang et al. · International Journal of Gynecological Cancer · 2017 · 70 citations · Full text

<u>C</u> ombination <u>A</u> TR (ceralasertib) and <u>P</u> A <u>R</u> P (olaparib) <u>I</u> nhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

Stephanie L. Wethington, Payal D. Shah, Lainie P. Martin et al. · Clinical Cancer Research · 2023 · 65 citations · Full text

Brain metastasis in gestational trophoblastic neoplasia: an update.

Nikki L. Neubauer, Nawar Latif, K. Kalakota et al. · PubMed · 2012 · 45 citations